MDL | MFCD00864257 |
---|---|
Molecular Weight | 313.30 |
Molecular Formula | C17H15NO5 |
SMILES | O=C(OC1=CC=C(NC(C)=O)C=C1)C2=CC=CC=C2OC(C)=O |
Prostaglandin [4] .
Benorylate (Salipran) is an esterified aspirin preparation whose antirheumatic properties are reported to be as good as those of aspirin
[1]
.
Benorylate (Salipran) causes a large decrease in the liver’s conversion rate of lactate into glucose, an important component of glucose homeostasis. Benorylate (Salipran) also impairs the urea synthesis rate from ammonia, another important function of the liver
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Benorylate (Salipran) is probably absorbed as the intact molecule which accounts for its good gastric tolerance
[3]
.
Benorylate (Salipran) could inhibit PG synthesis in laboratory animals and in human tissue
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : 125 mg/mL ( 398.98 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.1918 mL | 15.9591 mL | 31.9183 mL |
5 mM | 0.6384 mL | 3.1918 mL | 6.3837 mL |
10 mM | 0.3192 mL | 1.5959 mL | 3.1918 mL |